Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11851659 Compositions and methods for immunooncology

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Date Filed
March 21, 2018
0
Date of Patent
December 26, 2023
0
Patent Application Number
16498361
0
Patent Citations
‌
US Patent 7754482 Artificial antigen presenting cells and uses therefor
0
‌
US Patent 9422351 Isolated B7-H4 specific compositions and methods of use thereof
0
‌
US Patent 9446105 Chimeric antigen receptor specific for folate receptor β
0
‌
US Patent 9464140 Compositions and methods for treatment of cancer
0
‌
US Patent 9481728 Compositions and methods for treatment of cancer
0
‌
US Patent 9499629 Use of chimeric antigen receptor-modified T-cells to treat cancer
0
‌
US Patent 9518123 Compositions and methods for treatment of cancer
0
‌
US Patent 9540445 Compositions and methods for treatment of cancer
0
‌
US Patent 9572836 Methods for assessing the suitability of transduced T cells for administration
0
‌
US Patent 9573988 Effective targeting of primary human leukemia using anti-CD123 chimeric antigen receptor engineered T cells
0
•••
Patent Inventor Names
Hyungwook Lim
0
Jennifer Brogdon
0
Sarah Hesse
0
Ming-Wei Chen
0
Yi Yang
0
Morag Stewart
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11851659
0
Patent Primary Examiner
‌
Kevin K Hill
0
CPC Code
‌
C07K 14/70578
0
‌
C07K 2319/30
0
‌
C07K 2319/33
0
‌
C12N 2800/80
0
‌
C07K 14/70503
0
‌
C12N 15/1138
0
‌
C12N 15/86
0
‌
C12N 9/22
0
‌
C12N 2310/20
0

Find more entities like US Patent 11851659 Compositions and methods for immunooncology

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo